Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study

At Week 96 of the Single-Tablet Regimen (STaR) study, more treatment-naïve subjects that received rilpivirine/emtricitabine/tenofovir DF (RPV/FTC/TDF) developed resistance mutations compared to those treated with efavirenz (EFV)/FTC/TDF by population sequencing. Furthermore, more RPV/FTC/TDF-treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Viruses
Main Authors: Porter, Danielle P., Daeumer, Martin, Thielen, Alexander, Chang, Silvia, Martin, Ross, Cohen, Cal, Miller, Michael D., White, Kirsten L.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4690866/
https://ncbi.nlm.nih.gov/pubmed/26690199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v7122943
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados